Mark Alan Brown

Title: Mark Alan Brown: Innovator in Antibody Technology

Introduction

Mark Alan Brown is a notable inventor based in Malmö, Sweden. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies that target specific biochemical markers. His work has implications for various applications in medical research and diagnostics.

Latest Patents

Mark Alan Brown holds a patent for "Antibodies binding a gamma carboxyglutamic acid displaying epitope." This patent describes antibodies that are specifically designed to identify γ-carboxyglutamic acid (Gla). These antibodies are capable of recognizing Gla residues in proteins and peptides without reacting with glutamic (Glu) residues. The patent also outlines methods for preparing and identifying these antibodies, as well as techniques for detecting Gla in biological fluids and tissue specimens. Furthermore, the antibodies can be utilized for the immunopurification of Gla-containing proteins or peptides through methods such as immunoprecipitation or immunoaffinity chromatography. Mark Alan Brown has 1 patent to his name.

Career Highlights

Mark Alan Brown is associated with Protease Ab, a company that focuses on innovative solutions in the field of proteomics. His work at Protease Ab has allowed him to explore the potential of antibodies in various applications, enhancing the understanding of protein interactions and functions.

Collaborations

Throughout his career, Mark has collaborated with esteemed colleagues such as Johan Stenflo and Loisa Mary Stenberg. These collaborations have contributed to the advancement of research in antibody technology and its applications.

Conclusion

Mark Alan Brown's contributions to antibody technology exemplify the innovative spirit of modern biotechnology. His work continues to influence the field and offers promising avenues for future research and development.